Drug application
PRALIDOXIME CHLORIDE (AUTOINJECTOR) (PRALIDOXIME CHLORIDE)
Drugs@FDA NDA 018986 · MERIDIAN MEDCL TECHN
Key facts
| Drug name | PRALIDOXIME CHLORIDE (AUTOINJECTOR) |
|---|---|
| Active ingredients | PRALIDOXIME CHLORIDE |
| Application type | NDA |
| Application number | 018986 |
| Company | MERIDIAN MEDCL TECHN |
| Dosage forms | SOLUTION, INTRAMUSCULAR |
| Strength | 600MG/2ML (300MG/ML) |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Apr 26, 1983 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: